Peripheral CD8+ T Cells Predicts Immune-Related Adverse Events and Survival in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy

被引：0
|
作者：
Wu, K. [1 ]
Yang, S. [1 ]
Li, X. [1 ]
Xia, B. [1 ]
Ma, S. [1 ]
Chen, X. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hangzhou Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
immune-related adverse events; non-small cell lung cancer; Peripheral CD8+T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA09.03
引用
收藏
页码：S911 / S912
页数：2
相关论文
共 50 条
  • [1] Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
    Ricciuti, B.
    Genova, C.
    De Giglio, A.
    Brambilla, M.
    Bassanelli, M.
    Dal Bello, M. G.
    Baglivo, S.
    Metro, G.
    Grossi, F.
    Chiari, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S390 - S391
  • [2] Positive Correlation of Peripheral CD8+ T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Wu, Kan
    Xia, Bing
    Zhang, Jing
    Li, Xin
    Yang, Shaoyu
    Zhang, Minna
    Zhu, Lucheng
    Wang, Bing
    Xu, Xiao
    Ma, Shenglin
    Chen, Xueqin
    CANCERS, 2022, 14 (15)
  • [3] Association of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC)
    Saavedra Serrano, C.
    Barquin Garcia, A.
    Corral de la Fuente, E.
    Serrano Domingo, J. J.
    Albarran Artahona, V.
    Martin Huertas, R.
    Gomez Rueda, A.
    Olmedo Garcia, M. E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Impact of immune-related adverse events (irAE) on overall survival (OS) in patients treated with immunotherapy for non-small cell lung cancer (NSCLC).
    Owen, Dwight Hall
    Wei, Lai
    Villalona-Calero, Miguel Angel
    Bertino, Erin Marie
    He, Kai
    Shields, Peter G.
    Carbone, David P.
    Otterson, Gregory Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Association between immune-related adverse events and microbiome composition in patients with advanced non-small cell lung cancer treated with immunotherapy.
    Tonneau, Marion
    Richard, Corentin
    Nolin-Lapalme, Alexis
    Auclin, Edouard
    Benlaifaoui, Myriam
    Ponce, Mayra
    Al-Saleh, Afnan
    Blais, Normand
    Florescu, Marie
    Tehfe, Mustapha
    Malo, Julie
    Messaoudene, Meriem
    Okuma, Yusuke
    Hakozaki, Taiki
    Routy, Bertrand
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Immune-related adverse events (irAEs) and survival (OS) in metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immunotherapy
    Melian Sosa, M.
    Puchades, C.
    Mendez, J. A.
    Torres, A.
    Rodrigo, C.
    Gimeno, G.
    Rama, E.
    Martinez-Castillo, A.
    Caballero Daroqui, J.
    Gomez Codina, J.
    Juan-Vidal, O.
    Lorente, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Immune-related adverse events to predict survival in patients with advanced non-small cell lung cancer treated with nivolumab: A multicenter analysis.
    Ricciuti, Biagio
    De Giglio, Andrea
    Brambilla, Marta
    Bassanelli, Maria
    Metro, Giulio
    Ludovini, Vienna
    Baglivo, Sara
    Chiari, Rita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Immune-Related Adverse Effects of Immunotherapy in Patients With Advanced Non-Small Cell Lung Carcinoma
    Freitas, C.
    Veiga, F.
    Costa, J.
    Araujo, D.
    Novais-Bastos, H.
    Santos, V.
    Magalhaes, A.
    Hespanhol, V.
    Queiroga, H.
    Fernandes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S242 - S242
  • [9] Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
    Burke, Michael
    Rashdan, Sawsan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] The predictive value of peripheral blood CD4 cells ATP concentration for immune-related adverse events in advanced non-small cell lung cancer patients
    Hou, Kailian
    Ye, Weipeng
    Huang, Qunfeng
    Li, Weiyi
    Tan, Zhiqiong
    Tao, Na
    Yang, Dongheng
    Lin, Haoxin
    Deng, Zihao
    Xia, Yuanyuan
    Yu, Guifang
    BMC IMMUNOLOGY, 2024, 25 (01)
12345